The Claim
Magnesium deficiency is associated with elevated levels of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein, and this association contributes to insulin resistance in individuals with type 2 diabetes.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Low magnesium levels are linked to higher levels of specific inflammatory markers and are associated with increased insulin resistance in people with type 2 diabetes.
See the scientific wording
Magnesium deficiency is associated with increased systemic inflammation, characterized by elevated levels of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein, which contributes to insulin resistance in type 2 diabetes.
Low magnesium levels cause cells to produce more inflammatory signals like interleukin-6 and tumor necrosis factor-alpha, which activate enzymes that block insulin's ability to signal properly. This prevents sugar from entering cells and causes the liver and muscles to store less glycogen. At the same time, low magnesium directly reduces the activity of enzymes needed for insulin to work and for energy production, making insulin resistance worse.
What the research says
1 studyWhen your body doesn't have enough magnesium, it can cause inflammation and make it harder for insulin to do its job of moving sugar into cells, which makes type 2 diabetes worse.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.